{"context":{"query":">>mesh>>pharmgkb_clinical","source_dataset":"mesh","target_dataset":"pharmgkb_clinical"},"stats":{"queried":1,"total":12,"mapped":1},"pagination":{"has_next":false},"schema":"id|variant|gene|type|level_of_evidence|chemicals|phenotypes","mappings":[{"input":"D013274","source":"D013274|Stomach Neoplasms","targets":["RS10040363_XRCC4_1|rs10040363|XRCC4|Efficacy|3|fluorouracil;Platinum compounds;radiotherapy|Stomach Neoplasms","RS11615_ERCC1_11|rs11615|ERCC1|Efficacy|3|cisplatin|Neoplasm of esophagus;Ovarian Neoplasms;Stomach Neoplasms","RS1799983_NOS3_4|rs1799983|NOS3|Efficacy|3|anthracyclines and related substances;cyclophosphamide;doxorubicin;epirubicin;fluorouracil;methotrexate;oxaliplatin;Platinum compounds|Neoplasms;Ovarian Neoplasms;Stomach Neoplasms","RS1800566_NQO1_3|rs1800566|NQO1|Efficacy|3|epirubicin;fluorouracil;oxaliplatin|Metastatic neoplasm;Stomach Neoplasms","RS2075685_TMEM167A_XRCC4_1|rs2075685|TMEM167A,XRCC4|Efficacy|3|fluorouracil;Platinum compounds;radiotherapy|Stomach Neoplasms","RS2293347_EGFR_1|rs2293347|EGFR|Efficacy|3|fluorouracil|Stomach Neoplasms","RS2298881_ERCC1_1|rs2298881|ERCC1|Efficacy|3|fluorouracil;Platinum compounds;radiotherapy|Stomach Neoplasms","RS25648_VEGFA_1|rs25648|VEGFA|Efficacy|3|cisplatin;fluorouracil;oxaliplatin|Stomach Neoplasms","RS2854744_IGFBP3_1|rs2854744|IGFBP3|Efficacy|3|fluorouracil|Stomach Neoplasms","RS2960436_1|rs2960436||Efficacy|3|fluorouracil|Stomach Neoplasms","RS3212986_ERCC1_8|rs3212986|ERCC1|Efficacy|4|cisplatin|Neoplasm of esophagus;Ovarian Neoplasms;Stomach Neoplasms","RS662_PON1_1|rs662|PON1|Efficacy|3|epirubicin;fluorouracil;oxaliplatin|Neoplasms;Stomach Neoplasms"]}]}